The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
- Author(s)
- Petra Heffeter, Bihter Atil, Kushtrim Kryeziu, Diana Groza, Gunda Koellensperger, Wilfried Koerner, Ute Jungwirth, Thomas Mohr, Bernhard K. Keppler, Walter Berger
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- Medizinische Universität Wien, University of Natural Resources and Life Sciences
- Journal
- European Journal of Cancer
- Volume
- 49
- Pages
- 3366-3375
- No. of pages
- 10
- ISSN
- 0959-8049
- DOI
- https://doi.org/10.1016/j.ejca.2013.05.018
- Publication date
- 10-2013
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 104003 Inorganic chemistry, 302055 Oncology
- Keywords
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/7655b573-3482-401d-85e0-a1497a9b2ee1